It might seem like semantics. But whether a health condition qualifies as a disease can have a huge impact on patient experiences and treatment options.

Learn when to seek an obesity medicine specialist, how they differ from other doctors, and how they provide comprehensive, ...

The Medicare GLP-1 Bridge will start July 1. Regardless of the balance sheet, the responsible choice, says Dr Amy Faith Ho, is not to wait until obesity becomes a heart attack, a dialysis chair, or ...

A Medicare pilot beginning Wednesday will broaden access to medications like Wegovy and Zepbound. There are unique risks for those over 65.

Obesity has become one of the most closely tracked public health metrics of our time, and the numbers paint a picture that is ...

Body composition and obesity-related complications differ between men and women, but incretin-based medications confer benefits among all adults, according to a speaker at the Heart in Diabetes CME ...

Starting Wednesday, millions of Medicare-qualifying adults will have access to popular medications for weight loss at deep ...

Millions of Americans may be eligible to get blockbuster GLP-1 drugs like Wegovy and Zepbound for a much lower price starting July 1 under Medicare’s GLP-1 Bridge program.

A pharmaceutical company has been granted a court order that allows it to compel six of the UK’s biggest internet service providers (ISPs) to block users’ access to websites it identifies as selling ...

Taking medicine is a normal part of life for many older adults. A person may have one tablet for blood pressure, another for ...

The late 1900s ushered in a medicine renaissance. But as the nation marks its 250th anniversary, the foundation of healthcare ...

If your doctor prescribes a GLP-1 medication for weight loss but your insurance won’t cover it, you have options.